Detalhe da pesquisa
1.
ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming.
Acta Pharmacol Sin
; 44(11): 2282-2295, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37280363